Clinical Trial Update: IR-guided Ablation (IRGA) Combined With Stereotactic Ablative Radiation (SABR) for Large Lung Tumors [Phase 1]

View source ↗

Summary

Phase 1 trial of IR-guided ablation combined with stereotactic ablative radiation for large recurrent non-small cell lung cancer has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Snippet

Sponsor: New Mexico Cancer Research Alliance | Conditions: Recurrent Non-small Cell Lung Cancer | Phase 1 | Status: TERMINATED